Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research

Lin Chang, Carlo Di Lorenzo, Gianrico Farrugia, Frank A. Hamilton, Gary M. Mawe, Pankaj Jay Pasricha, John W. Wiley

Research output: Contribution to journalArticle

Abstract

In June 2016, the National Institutes of Health hosted a workshop on functional bowel disorders (FBDs), particularly irritable bowel syndrome, with the objective of elucidating gaps in current knowledge and recommending strategies to address these gaps. The workshop aimed to provide a roadmap to help strategically guide research efforts during the next decade. Attendees were a diverse group of internationally recognized leaders in basic and clinical FBD research. This document summarizes the results of their deliberations, including the following general conclusions and recommendations. First, the high prevalence, economic burden, and impact on quality of life associated with FBDs necessitate an urgent need for improved understanding of FBDs. Second, preclinical discoveries are at a point that they can be realistically translated into novel diagnostic tests and treatments. Third, FBDs are broadly accepted as bidirectional disorders of the brain−gut axis, differentially affecting individuals throughout life. Research must integrate each component of the brain−gut axis and the influence of biological sex, early-life stressors, and genetic and epigenetic factors in individual patients. Fourth, research priorities to improve diagnostic and management paradigms include enhancement of the provider−patient relationship, longitudinal studies to identify risk and protective factors of FBDs, identification of biomarkers and endophenotypes in symptom severity and treatment response, and incorporation of emerging “-omics” discoveries. These paradigms can be applied by well-trained clinicians who are familiar with multimodal treatments. Fifth, essential components of a successful program will include the generation of a large, validated, broadly accessible database that is rigorously phenotyped; a parallel, linkable biorepository; dedicated resources to support peer-reviewed, hypothesis-driven research; access to dedicated bioinformatics expertise; and oversight by funding agencies to review priorities, progress, and potential synergies with relevant stakeholders.

Original languageEnglish (US)
Pages (from-to)723-735
Number of pages13
JournalGastroenterology
Volume154
Issue number3
DOIs
StatePublished - Feb 1 2018

Fingerprint

Research
Endophenotypes
Education
Combined Modality Therapy
Irritable Bowel Syndrome
National Institutes of Health (U.S.)
Computational Biology
Routine Diagnostic Tests
Epigenomics
Longitudinal Studies
Biomarkers
Economics
Quality of Life
Databases
Therapeutics
Protective Factors

Keywords

  • Brain−Gut Axis
  • IBS
  • Intestinal Barrier Dysfunction
  • Microbiome

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Chang, L., Di Lorenzo, C., Farrugia, G., Hamilton, F. A., Mawe, G. M., Pasricha, P. J., & Wiley, J. W. (2018). Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research. Gastroenterology, 154(3), 723-735. https://doi.org/10.1053/j.gastro.2017.12.010

Functional Bowel Disorders : A Roadmap to Guide the Next Generation of Research. / Chang, Lin; Di Lorenzo, Carlo; Farrugia, Gianrico; Hamilton, Frank A.; Mawe, Gary M.; Pasricha, Pankaj Jay; Wiley, John W.

In: Gastroenterology, Vol. 154, No. 3, 01.02.2018, p. 723-735.

Research output: Contribution to journalArticle

Chang, L, Di Lorenzo, C, Farrugia, G, Hamilton, FA, Mawe, GM, Pasricha, PJ & Wiley, JW 2018, 'Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research', Gastroenterology, vol. 154, no. 3, pp. 723-735. https://doi.org/10.1053/j.gastro.2017.12.010
Chang, Lin ; Di Lorenzo, Carlo ; Farrugia, Gianrico ; Hamilton, Frank A. ; Mawe, Gary M. ; Pasricha, Pankaj Jay ; Wiley, John W. / Functional Bowel Disorders : A Roadmap to Guide the Next Generation of Research. In: Gastroenterology. 2018 ; Vol. 154, No. 3. pp. 723-735.
@article{77044bc50301476ebda9187c05a08ebd,
title = "Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research",
abstract = "In June 2016, the National Institutes of Health hosted a workshop on functional bowel disorders (FBDs), particularly irritable bowel syndrome, with the objective of elucidating gaps in current knowledge and recommending strategies to address these gaps. The workshop aimed to provide a roadmap to help strategically guide research efforts during the next decade. Attendees were a diverse group of internationally recognized leaders in basic and clinical FBD research. This document summarizes the results of their deliberations, including the following general conclusions and recommendations. First, the high prevalence, economic burden, and impact on quality of life associated with FBDs necessitate an urgent need for improved understanding of FBDs. Second, preclinical discoveries are at a point that they can be realistically translated into novel diagnostic tests and treatments. Third, FBDs are broadly accepted as bidirectional disorders of the brain−gut axis, differentially affecting individuals throughout life. Research must integrate each component of the brain−gut axis and the influence of biological sex, early-life stressors, and genetic and epigenetic factors in individual patients. Fourth, research priorities to improve diagnostic and management paradigms include enhancement of the provider−patient relationship, longitudinal studies to identify risk and protective factors of FBDs, identification of biomarkers and endophenotypes in symptom severity and treatment response, and incorporation of emerging “-omics” discoveries. These paradigms can be applied by well-trained clinicians who are familiar with multimodal treatments. Fifth, essential components of a successful program will include the generation of a large, validated, broadly accessible database that is rigorously phenotyped; a parallel, linkable biorepository; dedicated resources to support peer-reviewed, hypothesis-driven research; access to dedicated bioinformatics expertise; and oversight by funding agencies to review priorities, progress, and potential synergies with relevant stakeholders.",
keywords = "Brain−Gut Axis, IBS, Intestinal Barrier Dysfunction, Microbiome",
author = "Lin Chang and {Di Lorenzo}, Carlo and Gianrico Farrugia and Hamilton, {Frank A.} and Mawe, {Gary M.} and Pasricha, {Pankaj Jay} and Wiley, {John W.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1053/j.gastro.2017.12.010",
language = "English (US)",
volume = "154",
pages = "723--735",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Functional Bowel Disorders

T2 - A Roadmap to Guide the Next Generation of Research

AU - Chang, Lin

AU - Di Lorenzo, Carlo

AU - Farrugia, Gianrico

AU - Hamilton, Frank A.

AU - Mawe, Gary M.

AU - Pasricha, Pankaj Jay

AU - Wiley, John W.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - In June 2016, the National Institutes of Health hosted a workshop on functional bowel disorders (FBDs), particularly irritable bowel syndrome, with the objective of elucidating gaps in current knowledge and recommending strategies to address these gaps. The workshop aimed to provide a roadmap to help strategically guide research efforts during the next decade. Attendees were a diverse group of internationally recognized leaders in basic and clinical FBD research. This document summarizes the results of their deliberations, including the following general conclusions and recommendations. First, the high prevalence, economic burden, and impact on quality of life associated with FBDs necessitate an urgent need for improved understanding of FBDs. Second, preclinical discoveries are at a point that they can be realistically translated into novel diagnostic tests and treatments. Third, FBDs are broadly accepted as bidirectional disorders of the brain−gut axis, differentially affecting individuals throughout life. Research must integrate each component of the brain−gut axis and the influence of biological sex, early-life stressors, and genetic and epigenetic factors in individual patients. Fourth, research priorities to improve diagnostic and management paradigms include enhancement of the provider−patient relationship, longitudinal studies to identify risk and protective factors of FBDs, identification of biomarkers and endophenotypes in symptom severity and treatment response, and incorporation of emerging “-omics” discoveries. These paradigms can be applied by well-trained clinicians who are familiar with multimodal treatments. Fifth, essential components of a successful program will include the generation of a large, validated, broadly accessible database that is rigorously phenotyped; a parallel, linkable biorepository; dedicated resources to support peer-reviewed, hypothesis-driven research; access to dedicated bioinformatics expertise; and oversight by funding agencies to review priorities, progress, and potential synergies with relevant stakeholders.

AB - In June 2016, the National Institutes of Health hosted a workshop on functional bowel disorders (FBDs), particularly irritable bowel syndrome, with the objective of elucidating gaps in current knowledge and recommending strategies to address these gaps. The workshop aimed to provide a roadmap to help strategically guide research efforts during the next decade. Attendees were a diverse group of internationally recognized leaders in basic and clinical FBD research. This document summarizes the results of their deliberations, including the following general conclusions and recommendations. First, the high prevalence, economic burden, and impact on quality of life associated with FBDs necessitate an urgent need for improved understanding of FBDs. Second, preclinical discoveries are at a point that they can be realistically translated into novel diagnostic tests and treatments. Third, FBDs are broadly accepted as bidirectional disorders of the brain−gut axis, differentially affecting individuals throughout life. Research must integrate each component of the brain−gut axis and the influence of biological sex, early-life stressors, and genetic and epigenetic factors in individual patients. Fourth, research priorities to improve diagnostic and management paradigms include enhancement of the provider−patient relationship, longitudinal studies to identify risk and protective factors of FBDs, identification of biomarkers and endophenotypes in symptom severity and treatment response, and incorporation of emerging “-omics” discoveries. These paradigms can be applied by well-trained clinicians who are familiar with multimodal treatments. Fifth, essential components of a successful program will include the generation of a large, validated, broadly accessible database that is rigorously phenotyped; a parallel, linkable biorepository; dedicated resources to support peer-reviewed, hypothesis-driven research; access to dedicated bioinformatics expertise; and oversight by funding agencies to review priorities, progress, and potential synergies with relevant stakeholders.

KW - Brain−Gut Axis

KW - IBS

KW - Intestinal Barrier Dysfunction

KW - Microbiome

UR - http://www.scopus.com/inward/record.url?scp=85044868153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044868153&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2017.12.010

DO - 10.1053/j.gastro.2017.12.010

M3 - Article

C2 - 29288656

AN - SCOPUS:85044868153

VL - 154

SP - 723

EP - 735

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 3

ER -